Browse by Medical Category
News, publications and events from the Department of Surgery at Massachusetts General Hospital.
Call us for more information:
Friday, February 26, 2016 Mass General
Friday, January 01, 2016 Mass General
Friday, December 04, 2015 Mass General
Tuesday, November 17, 2015 Mass General
Sunday, November 15, 2015 Mass General
Monday, September 28, 2015 Mass General
Wednesday, September 23, 2015 Mass General
Saturday, August 15, 2015 Mass General
Tuesday, July 21, 2015 Mass General
Wednesday, July 08, 2015 Mass General
Tuesday, May 19, 2015 Mass General
Wednesday, May 06, 2015 Mass General
Friday, May 01, 2015 Mass General
Wednesday, February 25, 2015 Mass General
Friday, December 19, 2014 Mass General
Friday, December 12, 2014 Mass General
Monday, December 01, 2014 Mass General
Saturday, November 01, 2014 Research
Friday, October 24, 2014 Mass General
Thursday, October 23, 2014 Mass General
Tuesday, August 26, 2014 Mass General
Friday, August 08, 2014 Mass General
Friday, August 01, 2014 Mass General
Friday, July 25, 2014 Mass General
Wednesday, July 16, 2014 Mass General
Tuesday, July 15, 2014 Mass General
Friday, June 27, 2014 Mass General
Friday, June 20, 2014 Mass General
Friday, June 13, 2014 Mass General
Friday, May 16, 2014 Mass General
Friday, April 04, 2014 Mass General
Friday, March 21, 2014 Mass General
Friday, March 14, 2014 Mass General
Tuesday, January 21, 2014 Mass General
Friday, January 10, 2014 Mass General
Sunday, December 22, 2013 Mass General
Wednesday, December 18, 2013 Mass General
Friday, December 13, 2013 Mass General
Friday, November 15, 2013 Mass General
Thursday, November 07, 2013 Mass General
Sunday, November 03, 2013 Mass General
Monday, October 28, 2013 Mass General
Wednesday, October 02, 2013 Mass General
Friday, September 20, 2013 Mass General
Monday, September 09, 2013 Research
Wednesday, July 31, 2013 Research
Tuesday, July 16, 2013 Mass General
Wednesday, July 03, 2013 Research
Friday, June 07, 2013 Mass General
Friday, March 22, 2013 Mass General
Friday, March 15, 2013 Mass General
Monday, March 04, 2013 Mass General
Sunday, February 17, 2013 Mass General
Friday, January 11, 2013 Mass General
Wednesday, December 12, 2012 Mass General
Monday, December 03, 2012 Mass General
Friday, November 02, 2012 Mass General
Thursday, November 01, 2012 Mass General
Friday, October 26, 2012 Mass General
Tuesday, October 09, 2012 Mass General
Monday, October 08, 2012 Mass General
Monday, September 24, 2012 Mass General
Monday, September 03, 2012 Research
Thursday, August 23, 2012 Mass General
Friday, July 20, 2012 Mass General
Monday, July 16, 2012 Mass General
Wednesday, June 13, 2012 Mass General
Friday, May 18, 2012 Mass General
Tuesday, April 10, 2012 Mass General
Wednesday, March 21, 2012 Mass General
Tuesday, January 10, 2012 Mass General
Friday, December 23, 2011 Mass General
Friday, October 28, 2011 Mass General
Friday, October 07, 2011 Mass General
Thursday, August 04, 2011 Mass General
Thursday, June 02, 2011 Clinical
Friday, May 13, 2011 Mass General
Monday, April 25, 2011 Mass General
Friday, February 18, 2011 Mass General
Friday, February 04, 2011 Mass General
Friday, January 28, 2011 Mass General
Friday, December 17, 2010 Mass General
Friday, December 03, 2010 Clinical
Thursday, November 11, 2010 Mass General
Friday, October 01, 2010 Mass General
Friday, August 13, 2010 Mass General
Friday, May 21, 2010 Mass General
Friday, April 30, 2010 Mass General
Friday, December 04, 2009 Mass General
Wednesday, December 02, 2009 Clinical
Monday, August 24, 2009 Mass General
Monday, June 29, 2009 Mass General
Friday, May 08, 2009 Mass General
Wednesday, April 01, 2009 Mass General
Wednesday, March 11, 2009 Mass General
Friday, February 27, 2009 Mass General
Friday, December 05, 2008 Mass General
Wednesday, November 26, 2008 Mass General
Friday, November 07, 2008 Mass General
Wednesday, October 22, 2008 Mass General
MGH researchers have taken initial steps toward the creation of bioengineered human hearts using donor hearts stripped of components that would generate an immune response and cardiac muscle cells generated from induced pluripotent stem cells, which could come from a potential recipient.
Physicians in the Fireman Vascular Center at Massachusetts General Hospital (MGH) are now offering a new and less invasive method of treatment for carotid artery disease known as transcarotid artery revascularization, or TCAR.
Massachusetts General Hospital investigators have found that circulating tumor cell (CTC) clusters – which are more efficient in spreading cancer throughout the body than are single CTCs – can pass through capillary-sized blood vessels. Their findings suggest potential strategies to reduce clusters’ metastatic potential
A team led by MGH investigators has identified a set of characteristics – including differences in gene expression – that may indicate which patients recovering from severe burns are at greatest risk for repeat infections. Predicting the risk of infection before it occurs would indicate which patients should receive preventive treatment and reduce the unnecessary use of antibiotics in those at low risk.
The latest version of a microfluidic device for capturing rare circulating tumor cells is the first designed specifically to capture clusters of two or more cells, rather than single cells. Recent studies by MGH investigators and others have suggested that CTC clusters are significantly more likely to cause metastases than single circulating tumor cells.
A team of MGH investigators has made the first steps towards development of bioartificial replacement limbs suitable for transplantation.
Making an important step towards greater availability of hand and face transplants, MGH investigators have shown that a procedure developed to induce immune tolerance to organ transplants can induce tolerance to a model limb transplant in miniature swine.
A system developed by investigators at the MGH Center for Engineering in Medicine and the MGH Transplant Center has the potential to increase both the supply and the quality of donor organs for liver transplantation.
MGH investigators have identified the mechanism by which an enzyme produced in the intestinal lining helps to maintain a healthy population of gastrointestinal microbes.
Application of a technology currently used to disinfect food products may help to get around one of the most challenging problems in medicine today, the proliferation of bacteria resistant to antibiotics and other antimicrobial drugs.
A specially-bred strain of miniature swine lacking the molecule responsible for the rapid rejection of pig-to-primate organ transplants may provide a new source of skin grafts to treat seriously burned patients.
A system developed by investigators at the Massachusetts General Hospital Center for Engineering in Medicine allowed successful transplantation of rat livers after preservation for as long as four days, more than tripling the length of time organs currently can be preserved.
Two international research studies, both led by investigators affiliated with MGH and the Broad Institute, have uncovered new information about genes that may increase the risk of serious cardiac arrhythmias.
Circulating tumor cells captured with a microchip-based device developed at the MGH Center for Engineering in Medicine and the MGH Cancer Center can be cultured to establish cell lines that accurately reflect a tumor’s genetic mutation over time and changing susceptibility to therapeutic drugs.
A revised version of a surgical procedure to treat severe chronic migraine headaches led to significant symptom relief more than 90 percent of the time in a group of patients treated at Massachusetts General Hospital.
An immune-regulating cell present in lymph nodes may be able to halt severe cases of sepsis, an out-of-control inflammatory response that can lead to organ failure and death.
A microfluidic device developed at Massachusetts General Hospital may help study the epithelial-mesenchymal transition, a fundamental change in cellular characteristics that has been associated with the ability of tumor cells to migrate and invade other sites.
A team of MGH investigators has identified what may be a biomarker predicting the development of the dangerous systemic infection sepsis in patients with serious burns.
The first long-term study of a pioneering endoscopic laser treatment for early vocal-cord cancer, developed at MGH and previously shown to provide optimal voice outcomes, finds that it is as successful as traditional approaches in curing patients’ tumors while avoiding the damage to vocal quality caused by conventional treatments.
A new system for isolating rare circulating tumor cells – living solid tumor cells found at low levels in the bloodstream – shows significant improvement over previously developed devices and does not require prior identification of tumor-specific target molecules.
Feeding an intestinal enzyme to mice kept on a high-fat diet appears to prevent the development of metabolic syndrome – a group of symptoms associated with type 2 diabetes, cardiovascular disease and fatty liver – and to reduce symptoms in mice that already had the condition.
A device that measures the movement of key immune cells, developed by MGH investigators, may help determine which patients with serious burns are at risk for septic complications, and a novel treatment that directly addresses the cause of those complications could prevent many associated deaths.
Massachusetts General Hospital offers pulmonary thromboendarterectomy (PTE), a highly specialized operation to remove chronic blood clots in the lungs. Without surgery, patients who have this life-threatening disease will likely develop progressive shortness of breath so severe that it leads to heart failure.
MGH investigators have developed a novel strategy to protect the liver from drug-induced injury and improve associated drug safety. The team reports that inhibition of a type of cell-to-cell communication can protect against the damage caused by liver-toxic drugs such as acetaminophen.
MGH surgeons have developed a new technique for reconstructing the larynx after surgery for advanced cancer. The approach uses cryopreserved aortas from deceased donors to replace removed larynx tissue and allows some patients to avoid a permanent tracheotomy and maintain voice and swallowing function.
New research by a team from the Broad Institute, Dana-Farber Cancer Institute, and Massachusetts General Hospital suggests that how cancer evade drug treatment may depend on the interplay between tumor cells and their healthy counterparts.
Massachusetts General Hospital has moved into the number one spot on the 2012-13 U.S. News & World Report’s “America’s Best Hospitals” list.
The elevated risk of melanoma among people with red hair and fair skin may be caused by more than just a lack of natural protection against ultraviolet radiation. Resarchers at the MGH Cutaneous Biology Research Center and Cancer Center have found that the type of skin pigment predominantly found in red-haired, fair-skinned individuals may itself contribute to the development of melanoma.
Serious traumatic injuries, including major burns, set off a "genomic storm" in human immune cells, altering around 80 percent of the cells' normal gene expression patterns.
Technical improvements to a microchip-based device for detecting and analyzing tumor cells in the bloodstream are revealing cellular differences that may reflect a tumor's aggressiveness and long-term response to treatment.
Combined targeted therapy against the BRAF/MAPK pathway with immunotherapy shows promise as a new therapeutic approach for the treatment of melanoma, according to results of a preclinical study by MGH researchers.
A group of hospitals in eight cities around the globe has successfully demonstrated that the use of a simple surgical checklist during major operations can lower the incidence of deaths and complications by more than one third.
A team of researchers from the Massachusetts General Hospital Center for Engineering in Medicine has found the first evidence of cell-to-cell communication by amino acids, the building blocks of proteins, rather than by known protein signaling agents such as growth factors or cytokines.
A report from a team of Massachusetts General Hospital physicians calls into question the longstanding belief that pulmonary embolism – the life-threatening blockage of a major blood vessel in the lungs – is caused in trauma patients by a blood clot traveling from vessels deep within the legs or lower torso.
Thursday, May 26, 2016
Thursday, April 28, 2016
Wednesday, November 04, 2015
Saturday, December 06, 2014
Sunday, November 02, 2014
Friday, March 01, 2013
David Rattner, MD, Co-Chief of the Massachusetts General Hospital Digestive Healthcare Center describes how chronic heartburn can lead to other serious conditions, who is most at risk and how Barrett's esophagus and esophageal cancer can be diagnosed and treated.
Michael Jaff, DO, Medical Director of the Massachusetts General Hospital Fireman Vascular Center explains how carotid artery disease can cause a stroke, unless it is found early and treated, and how you can identify your risk for this condition.
Alice Shaw, MD, thoracic oncologist at the Mass General Cancer Center, says patients with lung cancer can benefit from genetic testing, particularly if they are young non-smokers. Learn more about personalized treatment for lung cancer and new "smart drugs" that target a tumor's specific genetic mutation to slow the cancer's growth, and in some cases, reduce it significantly.
Watch 46-year-old Frank Robinson tell the story of his life-saving experience at Mass General after a massive coronary.
Since 1811, people have counted on Mass General for answers, innovations and medical leadership. As our third century dawns, we remain ready to serve.
Dr. Richard Cambria, chief of vascular surgery at Mass General, says family history can provide clues.
The Ferguson-Ottinger Endowed Fund for Surgical Residents supports a visiting professorship, educational and networking opportunities for surgical residents at Massachusetts General Hospital.
W.G. (Jay) Austen Jr., MD, Chief of Plastic and Reconstructive Surgery at Massachusetts General Hospital, discusses a cutting edge procedure done at Mass General: Plastic Surgery for Migraines.
Diagnosed with idiopathic pulmonary fibrosis, Thomas Derigo, a husband and father to two teenage girls, had only one option: lung transplantation. Under the expert care of his team at Mass General, Thomas’s transplantation was a success, giving him the ability to live life normally and do the things he loves the most.
An ultrasound at 19 weeks showed that Andrew Johnson would be born with kidney functionality complications. Fortunately for Andrew, his mother was a compatible donor, and when he was strong enough, Andrew underwent kidney transplantation at MassGeneral Hospital for Children Transplant Center. “Everyone was so nervous that day,” Tara Johnson states. “I was elated.”
Thor Sundt, MD, chief of cardiac surgery and director of the Corrigan Minehan Heart Center, talks about heart valve options for patients undergoing heart valve surgery.
Jonathan Passeri, MD, co-director of the Mass General Heart Valve Program and director of Interventional Echocardiography, talks about aortic valve stenosis and answers common questions about symptoms to look out for and treatment options.
For two years, Amy DeStefano struggled with increasing heart complications, leaving her needing a heart transplantation. Through one of Mass General’s clinical trials, Amy became the first person in New England to receive a "heart in a box" transplant. The device circulates blood through the donated heart, keeping it beating and giving doctors more time to perform a transplant.
LINX® Reflux Management System is an innovative minimally invasive procedure used by Massachusetts General Hospital surgeons to treat appropriately selected patients experiencing symptoms of gastroesophageal reflux disease (GERD). For more information, visit massgeneral.org/LINX
Per oral endoscopic myotomy (POEM) is a minimally invasive procedure used by surgeons at Massachusetts General Hospital to treat eligible patients experiencing symptoms of achalasia. For more information, visit massgeneral.org/POEM
Minimally invasive esophagectomy (MIE) is a procedure performed by Massachusetts General Hospital surgeons using small incisions to remove a diseased esophagus and reconstruct the gastrointestinal tract. For more information, visit massgeneral.org/MIE
Sareh Parangi, MD, endocrine surgeon in the Thyroid Nodule Program at Massachusetts General Hospital, discusses thyroid nodule biopsy results and treatment recommendations.
Roy Phitayakorn, MD, endocrine surgeon, and Giuseppe Barbesino, MD, endocrinologist, of the Thyroid Nodule Program at Massachusetts General Hospital discuss outcomes and ongoing care after thyroid surgery.
Back to Top